U.S. University Sets New Try For Hepatitis Drug In China
This article was originally published in PharmAsia News
Executive Summary
Sometimes a scandal in one country, such as China, can have an impact on drug making a world away. University of Georgia researchers discovered the drug clevudine to treat hepatitis B, and the UGA Research Foundation plan to market it in China last year, potentially to treat a large volume of patients. But China's drug approval agency was hampered in its work as its former chief was tried, convicted and executed on bribery charges. The foundation took the drug to South Korea instead and saw $1.1 million in sales, its technology commercialization director reports. UGA had expected even more in China, but testing in China has resumed. (Click here for more